Elbrit Life Sciences
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Triglimibrit 1mg/500mg/0.3mg Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Triglimibrit 1mg/500mg/0.3mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Triglimibrit 1mg/500mg/0.3mg Tablet SR is to be taken empty stomach.
Triglimibrit 1mg/500mg/0.3mg Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Triglimibrit 1mg/500mg/0.3mg Tablet SR is a combination medication containing Glimepiride, Metformin and Voglibose for the treatment of type 2 diabetes mellitus (DM). It works by improving blood glucose levels in adults through diet and exercise. Glimepiride increases insulin release, metformin decreases glucose production and Voglibose inhibits postprandial glucose absorption.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection. It is crucial to seek immediate medical attention if experiencing severe adverse reactions like dizziness or difficulty breathing.
Triglimibrit 1mg/500mg/0.3mg Tablet SR is contraindicated for patients with known allergies to the ingredients or excipients in this medicine. It's also advised against use in individuals with moderate to severe kidney disease and inflammatory bowel disease, ulcerative colitis, and underlying metabolic acidosis including diabetic ketoacidosis.
No, alcohol consumption while on this medication is not recommended as it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Triglimibrit 1mg/500mg/0.3mg Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include dizziness, headache, irritability, hunger, sweating, fast heart rate and feeling anxious or shaky. It may occur more frequently if you miss meals, drink alcohol, over-exercise or take other antidiabetic medications in combination.
Store this medicine in its original packaging, tightly closed. Refer to the accompanying label or packaging for specific storage instructions. Do not dispose of the medication down the drain. Ensure that it is inaccessible to children, pets and other individuals.